Published in Genomics and Genetics Weekly, July 29th, 2005
"The decline in age at PaC diagnosis over the past decade is partially attributable to prostate specific antigen (PSA) screening. We examined age at diagnosis over successive generations within PaC families," researchers in the United States reported.
"Families with at least two affected men were selected from the University of Michigan Prostate Cancer Genetics Project. The 1,345 individuals from 489 families were grouped into three generations. Risk of PaC diagnosis at a given age was estimated to increase 1.31 (95% CI=1.13-1.51) times...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics and Genetics Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.